Literature DB >> 17256792

IVIC syndrome is caused by a c.2607delA mutation in the SALL4 locus.

Irene Paradisi1, Sergio Arias.   

Abstract

The IVIC syndrome described in 1980 in a large Venezuelan family, is an autosomal dominant condition characterized by upper limbs anomalies (radial ray defects, carpal bones fusion), extraocular motor disturbances, congenital bilateral non-progressive mixed hearing loss; other less consistent malformations include heart involvement, mild thrombocytopenia and leukocytosis (before age 50), shoulder girdle hypoplasia, imperforate anus, kidney malrotation or rectovaginal fistula. Since 2002, mutations in the SALL4 locus have been reported producing phenotypic features quite similar to those in IVIC syndrome; this gene was thus proposed as a candidate for the condition. A segregation analysis of four SNPs in exon 2 (c.1520T > G, c.1860A > G, c.2037C > T, and c.2392A > C) was carried out in 14 affected and in 15 normal family members. Haplotype T;A;C;A was found to always segregate with the disease. Sequencing the whole coding regions revealed one heterozygous base deletion in exon 3 (c.2607delA) causing a premature stop signal 44 codons downstream (p.Q869fsX44) which segregates with the phenotype, being absent in controls. The large number of affected individuals presumably carrying the same mutation (n = 26) with quite different degrees of involvement allowed a discussion about possible mechanisms for the SALL4 action. The finding of a SALL4 mutation in a family with such a wide pleiotropic spectrum proves that at least Okihiro, acro-renal-ocular and IVIC syndromes are allelic entities. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256792     DOI: 10.1002/ajmg.a.31603

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis.

Authors:  Li Chai
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor.

Authors:  Feikun Yang; Yixin Yao; Yongping Jiang; Luo Lu; Yupo Ma; Wei Dai
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 3.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

4.  SALL4 is a key transcription regulator in normal human hematopoiesis.

Authors:  Chong Gao; Nikki R Kong; Ailing Li; Hiro Tatetu; Shikiko Ueno; Youyang Yang; Jie He; Jianchang Yang; Yupo Ma; Grace S Kao; Daniel G Tenen; Li Chai
Journal:  Transfusion       Date:  2012-08-31       Impact factor: 3.157

Review 5.  The role of stem cell factor SALL4 in leukemogenesis.

Authors:  Chong Gao; Nikki R Kong; Li Chai
Journal:  Crit Rev Oncog       Date:  2011

Review 6.  SALL4, the missing link between stem cells, development and cancer.

Authors:  Hiro Tatetsu; Nikki R Kong; Gao Chong; Giovanni Amabile; Daniel G Tenen; Li Chai
Journal:  Gene       Date:  2016-02-16       Impact factor: 3.688

7.  Immunoexpression of SALL4 in Wilms tumors and developing kidney.

Authors:  Jeremy Deisch; Jack Raisanen; Dinesh Rakheja
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

8.  A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells.

Authors:  Jianchang Yang; Chong Gao; Li Chai; Yupo Ma
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

9.  Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.

Authors:  Fei Yin; Xin Han; Shu-Kun Yao; Xiao-Ling Wang; Hui-Chai Yang
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

10.  Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.

Authors:  Liliang Hao; Yan Zhao; Zhen Wang; Hongzhuan Yin; Xin Zhang; Tao He; Shanshan Song; Shaolong Sun; Baosheng Wang; Zhijie Li; Qi Su
Journal:  J Mol Histol       Date:  2016-01-16       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.